155 related articles for article (PubMed ID: 30073689)
1. Cutaneous macroglobulinosis as the initial presentation of Waldenström macroglobulinemia in a patient with a history of diffuse large B-cell lymphoma.
Shakeri A; Kaffenberger BH; Gru AA
J Cutan Pathol; 2018 Dec; 45(12):962-964. PubMed ID: 30073689
[No Abstract] [Full Text] [Related]
2. Cutaneous Waldenstrom macroglobulinemia in transformation.
Appenzeller P; Leith CP; Foucar K; Scott AA; Bigler CF; Thompson CT
Am J Dermatopathol; 1999 Apr; 21(2):151-5. PubMed ID: 10218675
[TBL] [Abstract][Full Text] [Related]
3. Coexisting cutaneous macroglobulinosis and scleredema of Buschke in a patient with a Waldenström Macroglobulinemia.
Roupie AL; Battistella M; Talbot A; Jachiet M; Bouaziz JD; Vignon-Pennamen MD; Royer B; Fermand JP; Arnulf B; Harel S
J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):e104-e106. PubMed ID: 30267590
[No Abstract] [Full Text] [Related]
4. Primary malignant lymphoma of the uterus: a report of four cases.
Terada T
Eur J Gynaecol Oncol; 2016; 37(2):159-60. PubMed ID: 27172736
[No Abstract] [Full Text] [Related]
5. Cutaneous marginal zone B-cell lymphoma in a patient previously diagnosed with cutaneous Waldenström macroglobulinemia.
Mitchum M; Scorza M; Thomas B; Galeckas K
J Am Acad Dermatol; 2010 Aug; 63(2):e59-61. PubMed ID: 20633795
[No Abstract] [Full Text] [Related]
6. Cutaneous macroglobulinosis: a report of 2 cases.
Gressier L; Hotz C; Lelièvre JD; Carlotti A; Buffet M; Wolkenstein P; Bagot M; Melica G; Ortonne N
Arch Dermatol; 2010 Feb; 146(2):165-9. PubMed ID: 20157027
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous macroglobulinosis.
Hanke CW; Steck WD; Bergfeld WF; Valenzuela R; Weick JK; Young JR; Gross EG
Arch Dermatol; 1980 May; 116(5):575-7. PubMed ID: 6769394
[TBL] [Abstract][Full Text] [Related]
8. [Richter syndrome with exclusively cutaneous involvement].
Jiménez C; Ribera JM; Juncá J; Millá F; Vaquero M; Feliu E
Sangre (Barc); 1993 Feb; 38(1):67-9. PubMed ID: 8470039
[No Abstract] [Full Text] [Related]
9. Evaluation and Management of Disease Transformation in Waldenström Macroglobulinemia.
Talaulikar D; Tomowiak C; Toussaint E; Morel P; Kapoor P; Castillo JJ; Delmer A; Durot E
Hematol Oncol Clin North Am; 2023 Aug; 37(4):787-799. PubMed ID: 37246087
[TBL] [Abstract][Full Text] [Related]
10. M protein deposition in the skin: a rare manifestation of Waldenström macroglobulinemia.
Oberschmid B; Siebolts U; Mechtel D; Kreibich U; Beller A; Wickenhauser C
Int J Hematol; 2011 Mar; 93(3):403-405. PubMed ID: 21384096
[No Abstract] [Full Text] [Related]
11. Cutaneous manifestations as initial presentation of Waldenstrom's macroglobulinemia.
Abdallah-Lotf M; Bourgeois-Droin C; Perronne V; Fouchard N; Michel S; Launay-Russ E; Granier F
Eur J Dermatol; 2003; 13(1):90-2. PubMed ID: 12609792
[TBL] [Abstract][Full Text] [Related]
12. Histological transformation to diffuse large B-cell lymphoma in patients with Waldenström macroglobulinemia.
Castillo JJ; Gustine J; Meid K; Dubeau T; Hunter ZR; Treon SP
Am J Hematol; 2016 Oct; 91(10):1032-5. PubMed ID: 27415417
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous macroglobulinosis with monotypic plasma cells: a specific manifestation of Waldenström macroglobulinemia.
Spicknall KE; Dubas LE; Mutasim DF
J Cutan Pathol; 2013 May; 40(5):440-4. PubMed ID: 23578179
[No Abstract] [Full Text] [Related]
14. Tumoral macroglobulinosis of the skin: In situ release of IgM.
Bonnetblanc JM; Bedane C; Fayol J; Labrousse F
Acta Derm Venereol; 2006; 86(1):63-4. PubMed ID: 16585994
[No Abstract] [Full Text] [Related]
15. Cutaneous macroglobulinosis with Waldenström macroglobulinemia.
Hassab-El-Naby HMM; El-Khalawany M; Rageh MA
JAAD Case Rep; 2020 Aug; 6(8):771-775. PubMed ID: 32760775
[No Abstract] [Full Text] [Related]
16. Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Clinicopathologic features of 12 cases.
Lin P; Mansoor A; Bueso-Ramos C; Hao S; Lai R; Medeiros LJ
Am J Clin Pathol; 2003 Aug; 120(2):246-53. PubMed ID: 12931555
[TBL] [Abstract][Full Text] [Related]
17. Initial Evaluation of the Patient with Waldenström Macroglobulinemia.
Castillo JJ; Treon SP
Hematol Oncol Clin North Am; 2018 Oct; 32(5):811-820. PubMed ID: 30190019
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous Macroglobulinosis Presenting as Serpiginous Purpura, a Case Report and Literature Review.
Sukanjanapong S; Chanprapaph K; Rutnin S; Boonsakan P; Pukiat S
Clin Cosmet Investig Dermatol; 2021; 14():1057-1064. PubMed ID: 34471370
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous macroglobulinosis. A case report with unique ultrastructural findings.
Lowe L; Fitzpatrick JE; Huff JC; Shanley PF; Golitz LE
Arch Dermatol; 1992 Mar; 128(3):377-80. PubMed ID: 1550371
[TBL] [Abstract][Full Text] [Related]
20. Coexistent adrenal diffuse large B cell lymphoma in a patient with Waldenström's macrogloblinemia/lymphoplasmacytic lymphoma.
Shingaki S; Yoshiki Y; Yamamoto K; Ota Y; Suzuki K
Ann Hematol; 2016 Oct; 95(10):1723-4. PubMed ID: 27365139
[No Abstract] [Full Text] [Related]
[Next] [New Search]
